Advertisement

Research Article Free access | 10.1172/JCI119863

Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma.

W R Henderson Jr, E Y Chi, R K Albert, S J Chu, W J Lamm, Y Rochon, M Jonas, P E Christie, and J M Harlan

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Find articles by Henderson, W. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Find articles by Chi, E. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Find articles by Albert, R. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Find articles by Chu, S. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Find articles by Lamm, W. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Find articles by Rochon, Y. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Find articles by Jonas, M. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Find articles by Christie, P. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Find articles by Harlan, J. in: JCI | PubMed | Google Scholar

Published December 15, 1997 - More info

Published in Volume 100, Issue 12 on December 15, 1997
J Clin Invest. 1997;100(12):3083–3092. https://doi.org/10.1172/JCI119863.
© 1997 The American Society for Clinical Investigation
Published December 15, 1997 - Version history
View PDF
Abstract

Immunized mice after inhalation of specific antigen have the following characteristic features of human asthma: airway eosinophilia, mucus and Th2 cytokine release, and hyperresponsiveness to methacholine. A model of late-phase allergic pulmonary inflammation in ovalbumin-sensitized mice was used to address the role of the alpha4 integrin (CD49d) in mediating the airway inflammation and hyperresponsiveness. Local, intrapulmonary blockade of CD49d by intranasal administration of CD49d mAb inhibited all signs of lung inflammation, IL-4 and IL-5 release, and hyperresponsiveness to methacholine. In contrast, CD49d blockade on circulating leukocytes by intraperitoneal CD49d mAb treatment only prevented the airway eosinophilia. In this asthma model, a CD49d-positive intrapulmonary leukocyte distinct from the eosinophil is the key effector cell of allergen-induced pulmonary inflammation and hyperresponsiveness.

Version history
  • Version 1 (December 15, 1997): No description
Advertisement
Advertisement